Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ISRCTN12839523) titled 'A clinical trial of nebulized (fine spray) surfactant (chemical compounds that decrease the surface tension between two liquids) for the treatment of severe COVID-19 and viral pneumonia in adults (COVSurf)' on Aug. 8.
Study Type: Interventional
Study Design:
Randomized controlled open-label study (Safety, Efficacy)
Primary Sponsor: University Hospital Southampton NHS Foundation Trust
Condition:
Viral Pneumonia, including COVID-19
Infections and Infestations
Intervention:
For the treatment arm, patients will be administered surfactant via COVSurf Drug Delivery System, they will receive 5 vials (540mg) of Al...